Lack of Association Between Hemoglobin A1c and Continuous Glucose Monitor Metrics Among Individuals with Prediabetes

Jorge A Rodriguez1,2, Nadine E Palermo2,3, Wenyu Song1,2

  • 1Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital, Boston, Massachusetts, USA.

PubMed

Insights

Continuous glucose monitor (CGM) metrics do not reliably reflect hemoglobin A1c (HbA1c) in prediabetes or normoglycemia. Associations are strongest in type 2 diabetes, but weaken significantly in lower glycemic states.

Area of Science:

  • Endocrinology
  • Metabolic Health
  • Diabetes Technology

Background:

  • Continuous glucose monitors (CGMs) offer detailed glycemic insights.
  • The correlation between CGM metrics and hemoglobin A1c (HbA1c) in prediabetes and normoglycemia is not well-established.

Purpose of the Study:

  • To investigate the association between various CGM metrics and HbA1c across different glycemic statuses: type 2 diabetes, prediabetes, and normoglycemia.
  • To determine if standard CGM metrics can accurately reflect HbA1c levels in individuals without diabetes.

Main Methods:

  • Analysis of data from 972 individuals stratified by glycemic status (421 type 2 diabetes, 319 prediabetes, 232 normoglycemia).
  • Examined associations between eight CGM metrics and HbA1c using regression analysis.
  • Assessed interaction terms to evaluate differences across glycemic groups.

Main Results:

  • Strongest associations between CGM metrics and HbA1c were observed in the type 2 diabetes group, particularly mean glucose (standardized β = 0.79).
  • In prediabetes, associations were attenuated, with mean glucose showing a moderate relationship (standardized β = 0.22).
  • For normoglycemic individuals, CGM metrics showed minimal association with HbA1c, including a weak link with mean glucose (standardized β = 0.10) and no significant relationship for time in range.

Conclusions:

  • Standard CGM metrics should be interpreted cautiously and are not interchangeable with HbA1c measurements in individuals with prediabetes or normoglycemia.
  • Glycemic status significantly modifies the relationship between CGM-derived metrics and HbA1c.
  • Further research may be needed to establish appropriate interpretation guidelines for CGM data in non-diabetic glycemic states.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.1K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
835
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
3.9K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.2K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
6.4K